WallStreetZenWallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Vertex Pharmaceuticals revenue was $11.02B for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $2.9B, up 5.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRTX annual revenue was $11.0B, with 11.7% growth year-over-year.

VRTX past revenue growth

How has VRTX's revenue growth performed historically?

Company
11.66%
Industry
511.06%
Market
20.87%
VRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VRTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VRTX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VRTX revenue history

Current Revenue
$11.0B
Current Earnings
-$535.6M
Current Profit Margin
-4.9%

Be the first to know when VRTX announces revenue.

VRTX Revenue History By Year

VRTX Yearly RevenueVRTX RevenueVRTX ChangeVRTX Revenue Growth
2024-12-31$11.02B$1.15B+11.66%
2023-12-31$9.87B$938.50M+10.51%
2022-12-31$8.93B$1.36B+17.91%
2021-12-31$7.57B$1.37B+22.06%
2020-12-31$6.21B$2.04B+49.08%
2019-12-31$4.16B$1.12B+36.59%
2018-12-31$3.05B$558.95M+22.46%
2017-12-31$2.49B$786.48M+46.20%
2016-12-31$1.70B$669.84M+64.89%
2015-12-31$1.03B$451.92M+77.86%
2014-12-31$580.42M-$631.56M-52.11%
2013-12-31$1.21B-$315.07M-20.63%
2012-12-31$1.53B$116.42M+8.25%
2011-12-31$1.41B$1.27B+883.91%
2010-12-31$143.37M$41.48M+40.71%
2009-12-31$101.89M-$73.62M-41.94%
2008-12-31$175.50M-$23.51M-11.81%
2007-12-31$199.01M-$17.34M-8.02%
2006-12-31$216.36M$55.47M+34.47%
2005-12-31$160.89M$58.17M+56.63%
2004-12-31$102.72M$33.58M+48.56%
2003-12-31$69.14M-$25.63M-27.04%
2002-12-31$94.77M$9.47M+11.11%
2001-12-31$85.30M-$67.99M-44.35%
2000-12-31$153.28M$44.40M+40.77%
1999-12-31$108.89M$79.83M+274.76%
1998-12-31$29.06M-$14.74M-33.66%
1997-12-31$43.80M$25.20M+135.50%
1996-12-31$18.60M-$8.94M-32.45%
1995-12-31$27.53M$4.39M+18.96%
1994-12-31$23.15MN/AN/A

1 of 3

Vertex Pharmaceuticals Revenue FAQ

What was VRTX's revenue last quarter?

On Invalid Date, Vertex Pharmaceuticals (NASDAQ: VRTX) reported Q4 2024 revenue of $2.91 billion up 15.66% year over year. In the same quarter last year, Vertex Pharmaceuticals's revenue was $2.52 billion.

What was Vertex Pharmaceuticals's revenue in 2024?

Vertex Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $11.02 billion, a 11.66% increase year over year.

How much does Vertex Pharmaceuticals make in a day?

Based on Vertex Pharmaceuticals annual revenue for the past five years, VRTX makes an average of $23,890,465.75 per day.

What was Vertex Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Vertex Pharmaceuticals's revenue has grown 11.66% year over year. This is 499.4 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Vertex Pharmaceuticals's revenue in the past year totaled $11.02 billion.

How much does Vertex Pharmaceuticals make in a year?

Vertex Pharmaceuticals's revenue by year for the past five years is:
  • Vertex Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $11.02 billion, a 11.66% increase year over year.
  • Vertex Pharmaceuticals's annual revenue for Dec 31, 2023 was $9.87 billion, a 10.51% increase from 2022.
  • Vertex Pharmaceuticals's annual revenue for 2022 was $8.93 billion, a 17.91% increase from 2021.
  • Vertex Pharmaceuticals's annual revenue for 2021 was $7.57 billion, a 22.06% increase from 2020.
  • Vertex Pharmaceuticals's annual revenue for 2020 was $6.21 billion, a 49.08% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.